Similarly, the CLL international prognostic index (CLL-IPI) and the CLL WithOut Need of Treatment (CLL-WONT) incorporate TP53 aberrations as an independent predictor of shorter TTFT [25, 26]. Here, TP53 is linked to B-cell chronic lymphocytic leukemia.